Salient Capital Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-100,000
| Closed | -$135K | – | 212 |
|
|
2017
Q2 | $135K | Buy |
100,000
+40,000
| +67% | +$54K | ﹤0.01% | 207 |
|
|
2017
Q1 | $128K | Hold |
60,000
| – | – | ﹤0.01% | 251 |
|
|
2016
Q4 | $265K | Buy |
60,000
+10,000
| +20% | +$44.2K | 0.01% | 222 |
|
|
2016
Q3 | $243K | Buy |
50,000
+40,000
| +400% | +$194K | ﹤0.01% | 222 |
|
|
2016
Q2 | $33K | Buy |
+10,000
| New | +$33K | ﹤0.01% | 244 |
|